In the xenograft setting, RANKL inhibition using the molecular decoy OPG-Fc significantly inhibited tumor growth of a transplanted RANK-expressing KRas mutant lung adenocarcinoma, although these growth inhibitory effects were quantitatively small (Fig. 1D,E). This evidence concerns the gene TNFRSF11A and lung adenocarcinoma.